These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9177447)

  • 1. HLA and Hodgkin's disease: reply to Taylor and Gokhale.
    Dorak MT; Mills KI; Poynton CH; Burnett AK
    Leukemia; 1997 Jun; 11(6):892-3. PubMed ID: 9177447
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel HLA-DRB1 allele, HLA-DRB1*0465, was identified in a Hodgkin's lymphoma cell line.
    Witter K; Mautner J; Volgger A; Zahn R; Kauke T
    Tissue Antigens; 2008 Mar; 71(3):257-8. PubMed ID: 18194364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype associated: response to Dorak, Mills, Poynton and Burnett.
    Taylor GM; Gokhale DA
    Leukemia; 1996 Nov; 10(11):1850-1. PubMed ID: 8892697
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA class II polymorphism in Egyptian children with lymphomas.
    Al-Tonbary Y; Abdel-Razek N; Zaghloul H; Metwaly S; El-Deek B; El-Shawaf R
    Hematology; 2004 Apr; 9(2):139-45. PubMed ID: 15203870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA-DRB4 gene does not explain genetic susceptibility in HLA-DQ2-negative celiac disease.
    Partanen J
    Immunogenetics; 2000 Mar; 51(3):249-51. PubMed ID: 10752637
    [No Abstract]   [Full Text] [Related]  

  • 6. A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL.
    Dorak MT; Oguz FS; Yalman N; Diler AS; Kalayoglu S; Anak S; Sargin D; Carin M
    Leuk Res; 2002 Jul; 26(7):651-6. PubMed ID: 12008082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance.
    Chakravarti A; Halloran SL; Bale SJ; Tucker MA
    Genet Epidemiol; 1986; 3(6):407-15. PubMed ID: 3803911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA-DR53 and lack of association of DPB1 alleles with Hashimoto's thyroiditis in Japanese.
    Onuma H; Ota M; Sugenoya A; Fukushima H; Inoko H; Iida F
    Tissue Antigens; 1993 Sep; 42(3):150-2. PubMed ID: 7904384
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA antigens in familial Hodgkin's disease.
    Greene MH; McKeen EA; Li FP; Blattner WA; Fraumeni JF
    Int J Cancer; 1979 Jun; 23(6):777-80. PubMed ID: 468411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA in familial Hodgkin's disease. Results and a new hypothesis;
    Marshall WH; Barnard JM; Buehler SK; Crumley J; Larsen B
    Int J Cancer; 1977 Apr; 19(4):450-5. PubMed ID: 844915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnicity is a significant factor in the epidemiology of rubella and Hodgkin's disease.
    Honeyman MC; Menser MA
    Nature; 1974 Oct; 251(5474):441-2. PubMed ID: 4421071
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-A and -DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis.
    Wan XL; Kimura A; Dong RP; Honda K; Tamai H; Sasazuki T
    Hum Immunol; 1995 Feb; 42(2):131-6. PubMed ID: 7744616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible HLA role in a family with Hodgkin's disease.
    Nuñez-Roldan A; Martinez-Guibelalde F; Gomez-Garcia P; Gomerz-Pereira C; Nuñez-Ollero G; Torres-Gomez A
    Tissue Antigens; 1979 May; 13(5):377-8. PubMed ID: 494227
    [No Abstract]   [Full Text] [Related]  

  • 14. The HLA-DRB4 gene is present in half of the Spanish HLA-DQ2-negative celiac patients.
    Garrote JA; Arranz E; Blanco-Quirós A
    Immunogenetics; 2000 Oct; 51(12):1045-6. PubMed ID: 11061289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
    Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a new DRB4 allele (DRB4*0104).
    De Canck I; Demanet C; Mersch G; Jannes G; Rombout A; Rossau R; Van Waeyenberge C
    Tissue Antigens; 1996 Sep; 48(3):213-6. PubMed ID: 8896182
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of the DRB4 null gene, DRB4*0101102N, by PCR-SSP and its distinction from other DRB4 genes.
    O'Neill CM; Bunce M; Welsh KI
    Tissue Antigens; 1996 Mar; 47(3):245-8. PubMed ID: 8740776
    [No Abstract]   [Full Text] [Related]  

  • 18. The cell of origin in Hodgkin's disease: conclusions from in vivo and in vitro studies.
    Schaadt M; Burrichter H; Stein H; Pfreundschuh M; Fonatsch C; Diehl V
    Int Rev Exp Pathol; 1985; 27():185-202. PubMed ID: 3915745
    [No Abstract]   [Full Text] [Related]  

  • 19. Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method.
    Berberich FR; Berberich MS; King MC; Engleman EG; Grumet FC
    Hum Immunol; 1983 Apr; 6(4):207-17. PubMed ID: 6221004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA in familial Hodgkin's disease.
    Conte R; Lauria F; Zucchelli P
    J Immunogenet; 1983 Jun; 10(3):251-5. PubMed ID: 6875280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.